Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.

作者: Victor C. Lin , Shu-Pin Huang , Chao-Yuan Huang , Chia-Cheng Yu , Hsin-Ling Yin

DOI: 10.7150/IJMS.21428

关键词:

摘要: Background: Cancer stem cells (CSCs) are involved in tumor progression and drug resistance. We hypothesized that variants CSC marker genes influence treatment outcomes prostate cancer. Methods: Ten potentially functional single nucleotide polymorphisms (SNPs) seven genes, TACSTD2, PROM1, ITGA2, POU5F1, EZH2, PSCA, CD44, were selected for analysis of their association with disease recurrence by Kaplan-Meier Cox regression a cohort 320 patients localized cancer receiving radical prostatectomy. Results: identified one independent SNP, rs2394882, POU5F1 was associated (hazard ratio 0.32, 95% confidence interval 0.14-0.71, P = 0.005) after adjustment known clinical predictors. Further silico analyses revealed rs2394882 affects expression, which turn is significantly correlated aggressiveness patient prognosis. Conclusion: Our results suggest prognostically relevant cancer, possibly modulating the expression gene POU5F1.

参考文章(25)
Shu-Pin Huang, Eric Lévesque, Chantal Guillemette, Chia-Cheng Yu, Chao-Yuan Huang, Victor C. Lin, I-Che Chung, Lih-Chyang Chen, Isabelle Laverdière, Louis Lacombe, Yves Fradet, Ta-Yuan Chang, Hong-Zin Lee, Shin-Hun Juang, Bo-Ying Bao, Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer. International Journal of Cancer. ,vol. 135, pp. 2661- 2667 ,(2014) , 10.1002/IJC.28904
Marco Trerotola, Hira Lal Goel, Mauro Piantelli, Dave Adams, Lucia R Languino, Jing Li, Saverio Alberti, Zhong Jiang, Swati Rathore, CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. American Journal of Translational Research. ,vol. 2, pp. 135- 144 ,(2010)
Esra Guzel, Omer F. Karatas, Mehmet B. Duz, Mustafa Solak, Michael Ittmann, Mustafa Ozen, Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer The Prostate. ,vol. 74, pp. 1498- 1505 ,(2014) , 10.1002/PROS.22867
Bo-Ying Bao, Shu-Pin Huang, Yu-Hsuan Lan, Te-Ling Lu, Jiunn-Bey Pao, Ta-Yuan Chang, Hong-Zin Lee, Wen-Hui Yang, Chi-Jeng Hsieh, Lu-Min Chen, Li-Chia Huang, Wen-Chien Ting, Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer. BJUI. ,vol. 107, pp. 486- 492 ,(2011) , 10.1111/J.1464-410X.2010.09512.X
Matthieu Schoenhals, Alboukadel Kassambara, John De Vos, Dirk Hose, Jérôme Moreaux, Bernard Klein, Embryonic stem cell markers expression in cancers. Biochemical and Biophysical Research Communications. ,vol. 383, pp. 157- 162 ,(2009) , 10.1016/J.BBRC.2009.02.156
Andrey V. Ugolkov, Laurie J. Eisengart, Chunyan Luan, Ximing J. Yang, Expression analysis of putative stem cell markers in human benign and malignant prostate. The Prostate. ,vol. 71, pp. 18- 25 ,(2011) , 10.1002/PROS.21217
Norman J. Maitland, Anne T. Collins, Prostate Cancer Stem Cells: A New Target for Therapy Journal of Clinical Oncology. ,vol. 26, pp. 2862- 2870 ,(2008) , 10.1200/JCO.2007.15.1472
E M Hurt, B T Kawasaki, G J Klarmann, S B Thomas, W L Farrar, CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis British Journal of Cancer. ,vol. 98, pp. 756- 765 ,(2008) , 10.1038/SJ.BJC.6604242
Hongbo Hao, Yuji Guo, Shangming Liu, Yanmin Zhang, Jianli Wang, Huijuan Liu, Fuwu Wang, Kai Liu, Eng-Ang Ling, Aijun Hao, Shidou Zhao, Qiuhuan Yuan, Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. The Journal of Pathology. ,vol. 223, pp. 672- 682 ,(2011) , 10.1002/PATH.2827
Bo-Ying Bao, Jiunn-Bey Pao, Victor C. Lin, Chun-Nung Huang, Ta-Yuan Chang, Yu-Hsuan Lan, Te-Ling Lu, Hong-Zin Lee, Lu-Min Chen, Wen-Chien Ting, Chi-Jeng Hsieh, Shu-Pin Huang, Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease. Clinica Chimica Acta. ,vol. 411, pp. 1232- 1237 ,(2010) , 10.1016/J.CCA.2010.04.028